AKBA Akebia Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 5, 2026
$0,87
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$0,8152-Wochen-Tief
$3,2052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$235M
P/E (TTM)
-7.9
EPS (TTM)
$-0.11
Umsatz (TTM)
$219M
Ihre Abzeichen
52W-Spanne
$1–$3
Analystenbewertung
BUY
Kursziel
$4
P/E
-7.9
ROE
-109.4%
Nettogewinnmarge
-13.5%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
AKBA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$0.86
Marktkapitalisierung (MRQ)
$235M
P/E (TTM)
-7.9
EPS (TTM)
$-0.11
Umsatz (TTM)
$219M
ROE (TTM)
-109.4%
Verschuldungsgrad (MRQ)
2.0
52W-Spanne
$1–$3
AKBA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$236M2020-12-31 → 2025-12-31
EPS$-0.022020-12-31 → 2025-12-31
Freier Cashflow$68M2020-12-31 → 2025-12-31
Nettogewinnmarge-13.5%2020-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | AKBA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -7.95-Jahres-Durchschnitt ≈-22.9 | ≈-22.9 | · | · | |
| P/S (TTM) | 1.15-Jahres-Durchschnitt ≈1.9 | ≈1.9 | 5.2 | Unterbewertet | |
| K/B (MRQ) | 9.45-Jahres-Durchschnitt ≈-1.2 | ≈-1.2 | 4.5 | Überbewertet | |
| EV / EBITDA | 4.05-Jahres-Durchschnitt ≈-0.3 | ≈-0.3 | · | · | |
| Kurs / FCF (TTM) | 5.85-Jahres-Durchschnitt ≈-4.8 | ≈-4.8 | · | · | |
| Kurs / Cashflow (TTM) | 5.75-Jahres-Durchschnitt ≈-4.8 | ≈-4.8 | · | · | |
| EV / Revenue (EV / Umsatz) | 0.45-Jahres-Durchschnitt ≈1.7 | ≈1.7 | · | · | |
| EV / FCF | 1.45-Jahres-Durchschnitt ≈-5.3 | ≈-5.3 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | AKBA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -6.9%5-Jahres-Durchschnitt ≈-18.2% | ≈-18.2% | -320.8% | Spitzenklasse | |
| EBITDA Margin (EBITDA-Marge) | 10.0%5-Jahres-Durchschnitt ≈-18.1% | ≈-18.1% | -320.8% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | -12.7%5-Jahres-Durchschnitt ≈-26.0% | ≈-26.0% | -204.8% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -13.5%5-Jahres-Durchschnitt ≈-26.1% | ≈-26.1% | -391.6% | Spitzenklasse | |
| ROA (TTM) | -8.5%5-Jahres-Durchschnitt ≈-17.2% | ≈-17.2% | -31.8% | Spitzenklasse | |
| ROE (TTM) | -109.4%5-Jahres-Durchschnitt ≈90.2% | ≈90.2% | -36.9% | Spitzenklasse | |
| ROIC | 41.7% | · | 16.7% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | AKBA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 2.05-Jahres-Durchschnitt ≈-0.1 | ≈-0.1 | · | · | |
| Liquiditätsgrad (MRQ) | 1.45-Jahres-Durchschnitt ≈1.4 | ≈1.4 | 4.5 | Geringe Liquidität | |
| Quick Ratio | 1.45-Jahres-Durchschnitt ≈1.1 | ≈1.1 | 3.2 | Geringe Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 1.05-Jahres-Durchschnitt ≈0.0 | ≈0.0 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | AKBA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 47.5%5-Jahres-Durchschnitt ≈8.6% | ≈8.6% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -6.9%5-Jahres-Durchschnitt ≈-9.6% | ≈-9.6% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -4.3% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | AKBA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.85-Jahres-Durchschnitt ≈0.7 | ≈0.7 | 0.3 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 2.55-Jahres-Durchschnitt ≈3.5 | ≈3.5 | · | · | |
| Receivables Turnover (Forderungsumschlag) | 5.85-Jahres-Durchschnitt ≈5.6 | ≈5.6 | 5.3 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$1.2M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
49.6%
Nächster Bericht
Nov 09, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 5, 2026 | $-0.03 | $-0.04 | 33.2% |
| 31. März 2026 | Mai 11, 2026 | $-0.03 | $-0.03 | -4.9% |
| 31. Dezember 2025 | $-0.05 | $-0.03 | -96.1% | |
| 30. September 2025 | $0.00 | $-0.02 | 100.0% | |
| 30. Juni 2025 | $0.00 | $-0.02 | 100.0% | |
| 31. März 2025 | $0.03 | $-0.05 | 165.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $236M | $160M | $195M | $292M | $212M | $295M | $335M | $208M | $181M | $2M | $0 | $0 | |
| Cost of Revenue | $39M | $63M | $74M | $86M | $151M | $296M | $145M | $8M | · | · | · | · | |
| R&D Expense | $62M | $38M | $63M | $130M | $148M | $218M | $323M | $291M | $231M | $116M | $43M | $23M | |
| SG&A Expense | $107M | $107M | $100M | $139M | $174M | $154M | $149M | $87M | $27M | $22M | $18M | $15M | |
| Operating Expenses | $173M | $147M | $167M | $288M | $325M | $376M | $476M | $378M | $258M | $138M | $62M | $38M | |
| Operating Income | $23M | $-50M | $-46M | $-81M | $-265M | $-378M | $-286M | $-178M | $-77M | $-136M | $-62M | $-38M | |
| Interest Income | · | · | · | · | · | · | · | · | · | $901.0K | $510.0K | $206.0K | |
| Other Non-op | $58.0K | $94.0K | $887.0K | $3M | $2M | $2M | $-794.0K | $81.0K | $204.0K | $-188.0K | $287.0K | $700.0K | |
| Pretax Income | $-4M | $-69M | $-52M | $-94M | $-282M | $-385M | $-286M | $-172M | $-74M | $-136M | · | · | |
| Income Tax | $2M | $0 | $0 | $0 | $0 | $0 | $-7M | $-28M | · | · | · | · | |
| Net Income | $-5M | $-69M | $-52M | $-94M | $-282M | $-385M | $-280M | $-144M | $-74M | $-136M | $-61M | $-37M | |
| EPS (Basic) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | · | · | · | · | · | |
| EPS (Diluted) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | · | · | · | · | · | |
| Shares (Basic) | 257,157,782 | 210,946,658 | 187,465,448 | 182,782,680 | 165,949,695 | 138,463,152 | 118,395,919 | · | · | · | · | · | |
| Shares (Diluted) | 257,157,782 | 210,946,658 | 187,465,448 | 182,782,680 | 165,949,695 | 138,463,152 | 118,395,919 | · | · | · | · | · | |
| EBITDA | $23M | $-50M | $-46M | $-79M | $-263M | $-374M | $-284M | $-177M | $-79M | $-136M | $-62M | $-38M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $185M | $52M | $43M | $90M | $150M | $229M | $147M | $105M | $70M | $187M | $50M | $33M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $248M | $73M | $89M | $76M | |
| Receivables | $47M | $34M | $39M | $40M | $52M | $27M | $39M | $17M | $34M | $34M | · | $48.0K | |
| Inventory | $16M | $16M | $16M | $22M | $37M | $61M | $116M | $114M | · | · | · | · | |
| Prepaid Expense | $5M | $11M | $20M | $33M | $33M | $15M | $7M | $16M | $6M | $2M | $3M | $2M | |
| Other Current Assets | $4M | $7M | $6M | $17M | · | · | · | · | · | · | · | · | |
| Current Assets | $253M | $114M | $118M | $185M | $271M | $371M | $310M | $468M | $358M | $296M | $141M | $110M | |
| PP&E (Net) | $1M | $2M | $4M | $5M | $7M | $9M | $10M | $8M | $4M | $3M | $540.0K | $210.0K | |
| PP&E (Gross) | · | · | · | $15M | $14M | $14M | $14M | $10M | $5M | $3M | $687.0K | $261.0K | |
| Accum. Depreciation | · | · | · | $9M | $8M | $6M | $4M | $2M | $1M | $442.0K | $147.0K | $51.0K | |
| Goodwill | $59M | $59M | $59M | $59M | $59M | $55M | $55M | $55M | · | · | · | · | |
| Intangibles | · | $0 | $36M | $72M | $108M | $144M | $291M | $328M | · | · | · | · | |
| Other Non-current Assets | $60M | $37M | $12M | $5M | $50M | $38M | $76M | $137M | $2M | $1M | $1M | $305.0K | |
| Total Assets | $377M | $221M | $242M | $356M | $529M | $644M | $771M | $997M | $364M | $300M | $143M | $111M | |
| Accounts Payable | $21M | $15M | $15M | $18M | $34M | $41M | $39M | $43M | $7M | $2M | $2M | $2M | |
| Accrued Liabilities | $122M | $63M | $68M | $76M | $109M | $131M | $129M | $151M | $52M | $30M | $10M | $5M | |
| Current Liabilities | $163M | $81M | $100M | $130M | $261M | $187M | $208M | $266M | $141M | $114M | $12M | $7M | |
| Capital Leases | $0 | $4M | $9M | $29M | $34M | $25M | $28M | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $5M | $9M | $16M | $84M | $61M | $30M | $30M | $22.0K | $27.0K | $5.0K | $32.0K | |
| Total Liabilities | $344M | $270M | $272M | $351M | $455M | $397M | $376M | $361M | $242M | $232M | $12M | $7M | |
| Long-term Debt | $48M | $39M | $35M | $66M | $98M | $96M | $76M | · | · | · | · | · | |
| Total Debt | $48M | $39M | $35M | · | $98M | $96M | $76M | · | · | · | · | · | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0 | $0 | $0 | $0 | |
| Retained Earnings | $-1.68B | $-1.68B | $-1.61B | $-1.56B | $-1.46B | $-1.18B | $-794M | $-514M | $-371M | $-297M | $-161M | $-101M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | $162.0K | $162.0K | |
| AOCI | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $13.0K | $0 | $-261.0K | $-442.0K | $-42.0K | $-234.0K | $-56.0K | |
| Stockholders' Equity | $33M | $-49M | $-31M | $5M | $74M | $244M | $393M | $636M | $123M | $68M | $131M | $104M | |
| Liabilities + Equity | $377M | $221M | $242M | $356M | $529M | $644M | $771M | $997M | $364M | $300M | $143M | $111M | |
| Shares Outstanding | 265,424,818 | 224,848,992 | 194,582,539 | 184,135,714 | 177,000,963 | 148,074,085 | 121,674,568 | 116,887,518 | 47,612,619 | 38,615,709 | 30,662,218 | 20,370,624 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $2M | $2M | $2M | $2M | $899.0K | $617.0K | $296.0K | $96.0K | $49.0K | |
| Stock-based Comp | $11M | $8M | $9M | $18M | $23M | $24M | $12M | $19M | $9M | $6M | $5M | $6M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-7M | $-28M | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | $0 | $36M | $36M | $36M | $36M | $33M | $36M | $2M | · | · | · | · | |
| Restructuring | $0 | $58.0K | $181.0K | $16M | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | $2M | $5M | $247M | $15M | $55M | $11M | $188M | · | · | |
| Operating Cash Flow | $68M | $-41M | $-23M | $-73M | $-253M | $-110M | $-257M | $-97M | $-56M | $58M | $-52M | $-27M | |
| CapEx | $291.0K | $33.0K | $0 | $114.0K | $59.0K | $317.0K | $7M | $2M | $2M | $3M | $414.0K | $229.0K | |
| Investing Cash Flow | $-8M | $-33.0K | $0 | $-114.0K | $40M | $-40M | $211M | $37M | $-177M | $13M | · | · | |
| Debt Issued | · | · | · | $0 | $0 | $20M | $78M | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | $0 | $0 | $20M | $78M | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $468M | $373M | · | · | $104M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $162.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | $468M | $373M | · | · | $104M | |
| Financing Cash Flow | $73M | $50M | $-25M | $15M | $134M | $232M | $89M | $97M | $116M | $67M | · | · | |
| Net Change in Cash | $133M | $9M | $-49M | $-59M | $-79M | $81M | $43M | $36M | $-117M | $138M | $17M | $12M | |
| Free Cash Flow | $68M | $-41M | $-23M | $-73M | $-253M | $-111M | $-264M | $-99M | $-58M | $55M | $-53M | $-28M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 10.0% | -31.5% | -23.8% | -27.6% | -124.2% | -127.5% | -85.5% | -85.8% | · | · | · | · | |
| Net Margin | -2.3% | -43.3% | -26.7% | -32.2% | -132.4% | -129.8% | -83.5% | -69.1% | · | · | · | · | |
| Pretax Margin | -1.6% | -43.3% | -26.7% | -32.2% | -132.4% | -129.8% | -85.5% | -82.8% | · | · | · | · | |
| EBITDA Margin | 10.0% | -31.5% | -23.8% | -27.1% | -123.3% | -126.8% | -84.8% | -85.3% | · | · | · | · | |
| ROA | -1.8% | -30.0% | -19.9% | · | -48.4% | -54.2% | -31.6% | -21.1% | -23.2% | -61.3% | -47.8% | -50.8% | |
| ROE | -17.3% | 139.4% | 148.3% | · | -264.8% | -135.6% | -64.9% | -36.9% | -82.1% | -136.3% | -51.7% | 322.1% | |
| ROIC | 41.7% | · | · | · | -152.5% | -109.4% | -59.4% | -23.4% | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.4 | 1.2 | · | 1.1 | 2.0 | 1.5 | 1.8 | 2.5 | 2.6 | 11.9 | 16.0 | |
| Quick Ratio | 1.4 | 1.1 | 0.8 | · | 0.8 | 1.4 | 0.9 | 0.5 | 2.4 | 2.3 | 11.7 | 15.8 | |
| Debt / Equity | 1.5 | -0.8 | -1.1 | · | 1.3 | 0.4 | 0.2 | · | · | · | · | · | |
| LT Debt / Equity | 1.5 | -0.8 | -0.6 | · | 0.0 | 0.4 | 0.2 | · | · | · | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | · | 0.4 | 0.4 | 0.4 | 0.3 | · | · | 0.0 | 0.0 | |
| Inventory Turnover | 2.5 | 4.0 | 4.1 | · | 3.1 | 3.3 | 0.9 | 0.1 | · | · | · | · | |
| Receivables Turnover | 5.8 | 4.3 | 6.7 | · | 5.5 | 9.0 | 12.1 | 8.2 | · | · | · | 0.0 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.12 | $-0.22 | $-0.16 | · | $0.43 | $1.67 | $3.24 | $5.44 | $2.51 | $1.76 | $4.27 | $5.11 | |
| Revenue / Share | $0.92 | $0.76 | $1.04 | $1.60 | $1.29 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.26 | $-0.19 | $-0.12 | $-0.40 | $-1.52 | · | · | · | · | · | · | · | |
| Cash / Share | $0.70 | $0.23 | $0.22 | · | $0.85 | $1.54 | $1.21 | $0.90 | $1.47 | $4.85 | $1.62 | $1.61 | |
| EPS (TTM) | $-0.02 | $-0.33 | $-0.28 | $-0.52 | $-1.70 | $-2.78 | $-2.36 | $-1.86 | $-1.86 | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 47.5% | -17.7% | -33.5% | 38.2% | -28.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -6.9% | -8.9% | -12.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -4.3% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $236M | $160M | $195M | $292M | $212M | $295M | $335M | $208M | $181M | $2M | $0 | $0 | |
| Net Income TTM | $-5M | $-69M | $-52M | $-94M | $-282M | $-385M | $-280M | $-144M | $-74M | $-136M | $-61M | $-37M | |
| Market Cap | $427M | $427M | $241M | · | $400M | $415M | $769M | $646M | $708M | $402M | $396M | $237M | |
| Enterprise Value | $291M | $414M | $233M | · | $348M | $282M | $697M | · | · | · | · | · | |
| P/E | -80.5 | -5.8 | -4.4 | -1.1 | -1.3 | -1.0 | -2.7 | -3.0 | -8.0 | · | · | · | |
| P/S | 1.8 | 2.7 | 1.2 | · | 1.9 | 1.4 | 2.3 | 3.1 | 3.9 | 261.9 | · | · | |
| P/B | 13.1 | -8.7 | -7.9 | · | 5.2 | 1.7 | 1.9 | 1.0 | 5.9 | 5.9 | 3.0 | 2.3 | |
| P / Tangible Book | · | · | · | · | · | 9.2 | · | · | · | · | · | · | |
| P / Cash Flow | 6.3 | -10.5 | -10.3 | · | -1.6 | -3.8 | -3.0 | -6.6 | -12.6 | 6.9 | -7.6 | -8.6 | |
| P / FCF | 6.3 | -10.5 | -10.3 | · | -1.6 | -3.7 | -2.9 | -6.5 | -12.3 | 7.3 | -7.5 | -8.6 | |
| EV / EBITDA | 12.4 | -8.2 | -5.0 | · | -1.3 | -0.8 | -2.5 | · | · | · | · | · | |
| EV / FCF | 4.3 | -10.2 | -10.0 | · | -1.4 | -2.5 | -2.6 | · | · | · | · | · | |
| EV / Revenue | 1.2 | 2.6 | 1.2 | · | 1.6 | 1.0 | 2.1 | · | · | · | · | · | |
| Earnings Yield | -1.2% | -17.4% | -22.6% | -90.1% | -75.2% | -99.3% | -37.3% | -33.6% | -12.5% | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $49M | $54M | $58M | $59M | $62M | $57M | $46M | $37M | $44M | $33M | $56M | $42M | $56M | $40M | $56M | $49M | |
| Cost of Revenue | $10M | $12M | $13M | $9M | $10M | $8M | $20M | $14M | $17M | $12M | $19M | $18M | $17M | $20M | $-3M | $38M | |
| R&D Expense | $14M | $15M | $27M | $15M | $11M | $10M | $12M | $8M | $8M | $10M | $10M | $13M | $20M | $20M | $32M | $28M | |
| SG&A Expense | $28M | $30M | $26M | $29M | $27M | $26M | $28M | $27M | $27M | $25M | $25M | $23M | $27M | $25M | $30M | $32M | |
| Operating Expenses | $45M | $46M | $54M | $45M | $38M | $36M | $40M | $36M | $35M | $36M | $36M | $37M | $48M | $45M | $64M | $61M | |
| Operating Income | $-6M | $-5M | $-9M | $4M | $14M | $14M | $-14M | $-13M | $-9M | $-15M | $1M | $-13M | $-9M | $-26M | $-5M | $-50M | |
| Other Non-op | $-7.0K | $3.0K | $-117.0K | $-10.0K | $-28.0K | $213.0K | $55.0K | $-17.0K | $-39.0K | $95.0K | $658.0K | $-43.0K | $-10.0K | $282.0K | $434.0K | $1M | |
| Pretax Income | $-9M | $-9M | $-11M | $1M | $247.0K | $6M | $-23M | $-20M | $-9M | $-18M | $612.0K | $-14M | $-11M | $-27M | · | · | |
| Income Tax | $70.0K | $126.0K | $1M | $615.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-9M | $-9M | $-12M | $540.0K | $247.0K | $6M | $-23M | $-20M | $-9M | $-18M | $612.0K | $-14M | $-11M | $-27M | $-6M | $-54M | |
| EPS (Basic) | $-0.03 | $-0.03 | $-0.05 | $0.00 | $0.00 | $0.03 | $-0.10 | $-0.10 | $-0.04 | $-0.09 | $0.01 | $-0.08 | $-0.06 | $-0.15 | $-0.04 | $-0.29 | |
| EPS (Diluted) | $-0.03 | $-0.03 | $-0.05 | $0.00 | $0.00 | $0.03 | $-0.10 | $-0.10 | $-0.04 | $-0.09 | $0.01 | $-0.08 | $-0.06 | $-0.15 | $-0.03 | $-0.29 | |
| Shares (Basic) | 269,602,747 | 267,046,755 | · | 264,786,432 | 262,565,500 | 235,497,720 | · | 210,348,459 | 209,705,397 | 204,955,151 | · | 188,306,350 | 186,817,431 | 184,768,983 | · | 183,882,446 | |
| Shares (Diluted) | 269,602,747 | 267,046,755 | · | 274,372,722 | 271,104,020 | 241,602,853 | · | 210,348,459 | 209,705,397 | 204,955,151 | · | 188,306,350 | 186,817,431 | 184,768,983 | · | 183,882,446 | |
| EBITDA | $-6M | $-5M | · | $4M | $14M | $14M | · | $-13M | $-9M | $-15M | · | $-13M | $-9M | $-25M | · | $-48M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $163M | $185M | $166M | $137M | $113M | $52M | $34M | $39M | $42M | $43M | $47M | $54M | $57M | $90M | $145M | |
| Receivables | $54M | $63M | $47M | $66M | $73M | $62M | $34M | $32M | $30M | $27M | · | $23M | $20M | $18M | $40M | $23M | |
| Inventory | $13M | $13M | $16M | $19M | $17M | $20M | $16M | $20M | $24M | $26M | · | $18M | $21M | $21M | $22M | $40M | |
| Prepaid Expense | $7M | $5M | $5M | $7M | $8M | $9M | $11M | $13M | $19M | $19M | · | $22M | $24M | $25M | $33M | $30M | |
| Other Current Assets | $6M | $4M | $4M | $5M | $8M | $8M | $7M | $6M | $7M | $5M | · | · | · | · | $17M | · | |
| Current Assets | $230M | $243M | $253M | $258M | $235M | $204M | $114M | $100M | $112M | $113M | · | $110M | $118M | $121M | $185M | $238M | |
| PP&E (Net) | $2M | $956.0K | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | · | $4M | $4M | $5M | $5M | $6M | |
| Goodwill | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | $59M | · | $59M | $59M | $55M | $59M | $55M | |
| Intangibles | · | · | · | · | · | · | · | $9M | $18M | $27M | · | $45M | $54M | $63M | $72M | $81M | |
| Other Non-current Assets | $54M | $57M | $60M | $40M | $44M | $38M | $37M | $27M | $18M | $12M | · | $4M | $3M | $5M | $5M | $26M | |
| Total Assets | $350M | $363M | $377M | $364M | $346M | $310M | $221M | $207M | $220M | $225M | · | $235M | $254M | $277M | $356M | $436M | |
| Accounts Payable | $9M | $8M | $21M | $10M | $12M | $13M | $15M | $13M | $10M | $12M | · | $9M | $12M | $13M | $18M | $20M | |
| Accrued Liabilities | $110M | $125M | $122M | $106M | $92M | $71M | $63M | $52M | $54M | $54M | · | $63M | $56M | $46M | $76M | $87M | |
| Current Liabilities | $161M | $174M | $163M | $133M | $119M | $91M | $81M | $66M | $107M | $66M | · | $80M | $92M | $83M | $130M | $188M | |
| Capital Leases | $4M | · | $0 | $0 | $671.0K | $2M | $4M | $5M | $6M | $8M | · | $10M | $11M | $27M | $29M | $31M | |
| Other Non-current Liabilities | $562.0K | $681.0K | $2M | $5M | $5M | $5M | $5M | $5M | $7M | $7M | · | $9M | $17M | $13M | $16M | $74M | |
| Total Liabilities | $325M | $335M | $344M | $323M | $316M | $286M | $270M | $258M | $254M | $253M | · | $274M | $281M | $291M | $351M | $422M | |
| Long-term Debt | $50M | $49M | $48M | $48M | $47M | $47M | · | $38M | $38M | $30M | · | $43M | $42M | $50M | $66M | $66M | |
| Total Debt | $50M | $49M | · | $48M | $47M | $47M | · | $38M | $38M | $30M | · | $43M | $42M | $50M | · | $66M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | · | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |
| Retained Earnings | $-1.70B | $-1.69B | $-1.68B | $-1.67B | $-1.67B | $-1.67B | $-1.68B | $-1.66B | $-1.64B | $-1.63B | · | $-1.61B | $-1.60B | $-1.58B | $-1.56B | $-1.55B | |
| AOCI | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Stockholders' Equity | $25M | $27M | $33M | $42M | $29M | $25M | $-49M | $-50M | $-34M | $-27M | $-31M | $-39M | $-27M | $-14M | $5M | $14M | |
| Liabilities + Equity | $350M | $363M | $377M | $364M | $346M | $310M | $221M | $207M | $220M | $225M | · | $235M | $254M | $277M | $356M | $436M | |
| Shares Outstanding | 271,742,717 | 267,898,415 | 265,424,818 | 265,226,038 | 263,041,832 | 261,644,590 | 224,848,992 | 211,542,122 | 209,929,145 | 209,454,149 | 194,582,539 | 188,313,807 | 188,128,869 | 185,835,946 | 184,135,714 | 183,951,583 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | |
| Amort. of Intangibles | · | · | $0 | $0 | $0 | $0 | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Restructuring | $2M | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $58.0K | $0 | $169.0K | $-94.0K | $106.0K | $1M | $180.0K | |
| Operating Cash Flow | $4M | $-21M | $31M | $28M | $22M | $-14M | $-4M | $-7M | $-10M | $-19M | $-2M | $-7M | $4M | $-18M | $-55M | $34M | |
| CapEx | $1M | $62.0K | $70.0K | $77.0K | $126.0K | $18.0K | $2.0K | $2.0K | $29.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Investing Cash Flow | $-4M | $-62.0K | $-8M | $-77.0K | $-126.0K | $154.0K | $-2.0K | $-2.0K | $-29.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Financing Cash Flow | $-7M | $-926.0K | $-5M | $1M | $2M | $75M | $22M | $1M | $8M | $18M | $-1M | $50.0K | $-8M | $-16M | $-1.0K | $-33M | |
| Net Change in Cash | $-7M | $-22M | $18M | $29M | $24M | $62M | $18M | $-5M | $-2M | $-957.0K | $-4M | $-7M | $-4M | $-34M | $-55M | $868.0K | |
| Free Cash Flow | · | $-21M | · | · | · | $-14M | · | · | · | · | · | · | · | $-18M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -12.9% | -8.8% | · | 7.6% | 22.6% | 23.6% | · | -33.4% | -20.0% | -45.8% | · | -31.0% | -16.0% | -62.2% | · | -98.4% | |
| Net Margin | -18.1% | -16.9% | · | 0.92% | 0.40% | 10.7% | · | -53.5% | -19.7% | -55.2% | · | -34.5% | -19.8% | -65.3% | · | -105.9% | |
| Pretax Margin | -18.0% | -16.7% | · | 2.0% | 0.40% | 10.7% | · | -53.5% | -19.7% | -55.2% | · | · | · | · | · | · | |
| EBITDA Margin | -12.9% | -8.8% | · | 7.6% | 22.6% | 23.6% | · | -33.4% | -20.0% | -45.8% | · | -31.0% | -16.0% | -62.2% | · | -98.4% | |
| ROA | -2.6% | -2.7% | · | 0.19% | 0.09% | 2.3% | · | -9.1% | -3.6% | -7.2% | · | -4.3% | -2.9% | -6.5% | · | -10.0% | |
| ROE | -32.9% | -34.8% | · | -12.3% | -10.9% | -456.6% | · | 44.6% | 28.3% | 86.5% | · | 113.3% | -62.9% | -445.7% | · | -68.7% | |
| ROIC | -8.6% | -6.2% | · | 2.3% | · | · | · | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | · | 1.9 | 2.0 | 2.2 | · | 1.5 | 1.0 | 1.7 | · | 1.4 | 1.3 | 1.5 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.7 | 1.8 | 1.9 | · | 1.0 | 0.6 | 1.0 | · | 0.9 | 0.8 | 0.9 | · | 0.9 | |
| Debt / Equity | 2.0 | 1.8 | · | 1.1 | 1.6 | 1.9 | · | -0.8 | -1.1 | -1.1 | · | -1.1 | -1.6 | -3.5 | · | 4.8 | |
| LT Debt / Equity | 1.0 | 1.3 | · | 1.1 | 1.6 | 1.9 | · | -0.8 | -1.1 | -1.1 | · | -0.9 | -0.7 | -1.8 | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.3 | · | 0.7 | 0.8 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 1.0 | |
| Receivables Turnover | 0.8 | 0.9 | · | 1.2 | 1.2 | 1.3 | · | 1.4 | 1.8 | 1.5 | · | 1.8 | 1.1 | 1.0 | · | 1.3 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.09 | $0.10 | · | $0.16 | $0.11 | $0.09 | · | $-0.24 | $-0.16 | $-0.13 | · | $-0.21 | $-0.14 | $-0.08 | · | $0.08 | |
| Revenue / Share | $0.18 | $0.20 | · | $0.21 | $0.23 | $0.24 | · | $0.18 | $0.21 | $0.16 | · | $0.22 | $0.30 | $0.22 | · | $0.27 | |
| Cash Flow / Share | · | $-0.08 | · | · | · | $-0.06 | · | · | · | $-0.09 | · | · | · | $-0.09 | · | · | |
| Cash / Share | $0.57 | $0.61 | · | $0.63 | $0.52 | $0.43 | · | $0.16 | $0.19 | $0.20 | · | $0.25 | $0.28 | $0.31 | · | $0.79 | |
| EPS (TTM) | $-0.11 | $-0.08 | · | $-0.07 | $-0.17 | $-0.21 | · | $-0.22 | $-0.20 | $-0.22 | · | $-0.32 | $-0.53 | $-0.32 | · | $-0.89 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $219M | $232M | · | $225M | $204M | $185M | · | $170M | $174M | $187M | · | $194M | $201M | $271M | · | $294M | |
| Net Income TTM | $-30M | $-21M | · | $-16M | $-36M | $-45M | · | $-46M | $-40M | $-43M | · | $-59M | $-98M | $-58M | · | $-158M | |
| Market Cap | $310M | $372M | · | $724M | $957M | $502M | · | $279M | $214M | $383M | · | $215M | $172M | $104M | · | $58M | |
| Enterprise Value | $204M | $259M | · | $605M | $867M | $435M | · | $284M | $213M | $371M | · | $211M | $161M | $97M | · | $-21M | |
| P/E | -10.4 | -17.4 | · | -39.0 | -21.4 | -9.1 | · | -6.0 | -5.1 | -8.3 | · | -3.6 | -1.7 | -1.8 | · | -0.4 | |
| P/S | 1.4 | 1.6 | · | 3.2 | 4.7 | 2.7 | · | 1.6 | 1.2 | 2.0 | · | 1.1 | 0.9 | 0.4 | · | 0.2 | |
| P/B | 12.4 | 13.6 | · | 17.4 | 32.8 | 20.4 | · | -5.5 | -6.3 | -14.1 | · | -5.4 | -6.4 | -7.3 | · | 4.2 | |
| P / Cash Flow | · | -17.6 | · | · | · | -37.0 | · | · | · | -19.7 | · | · | · | -5.9 | · | · | |
| EV / Revenue | 0.9 | 1.1 | · | 2.7 | 4.3 | 2.4 | · | 1.7 | 1.2 | 2.0 | · | 1.1 | 0.8 | 0.4 | · | -0.1 | |
| Earnings Yield | -9.7% | -5.8% | · | -2.6% | -4.7% | -10.9% | · | -16.7% | -19.6% | -12.0% | · | -28.1% | -57.9% | -57.1% | · | -281.6% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Umsatz | $236M | $160M | $195M | · | $292M |
| Betriebsgewinnmarge % | 10.0% | -31.5% | -23.8% | · | -27.6% |
| Nettoergebnis | $-5M | $-69M | $-52M | · | $-94M |
| Verwässerte EPS | $-0.02 | $-0.33 | $-0.28 | · | $-0.52 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 1.5 | -0.8 | -1.1 | · | · |
| Liquiditätsgrad | 1.6 | 1.4 | 1.2 | · | · |
| Quick Ratio | 1.4 | 1.1 | 0.8 | · | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $68M | $-41M | $-23M | · | $-73M |
Institutionelle Eigentümer (13F) 180 Einreicher · $144.4M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
180
Gehaltener Wert
$144.4M
Neue Positionen
39
Geschlossene Positionen
35
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 39 (+4 vs. Vorquartal) | 35 (+8 vs. Vorquartal) | 68 (+25 vs. Vorquartal) | 34 (-20 vs. Vorquartal) | +6.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $25.786.481 | 16.016.448 | 17,86% | Aktien |
| BlackRock, Inc. | $22.784.466 | 19.986.374 | 15,78% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $12.907.243 | 11.322.143 | 8,94% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $10.432.737 | 9.151.524 | 7,23% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $7.671.148 | 6.727.302 | 5,31% | Aktien |
| STATE STREET CORP | $6.145.572 | 5.390.853 | 4,26% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $4.871.250 | 4.273.026 | 3,37% | Aktien |
| GOLDMAN SACHS GROUP INC | $4.205.650 | 3.689.167 | 2,91% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $3.644.130 | 3.196.605 | 2,52% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.888.734 | 2.533.977 | 2,00% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $2.777.807 | 2.436.673 | 1,92% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.622.499 | 2.300.438 | 1,82% | Aktien |
| NORTHERN TRUST CORP | $2.462.816 | 2.160.365 | 1,71% | Aktien |
| Nantahala Capital Management, LLC | $2.280.000 | 2.000.000 | 1,58% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.176.029 | 1.908.797 | 1,51% | Aktien |
| FMR LLC | $2.133.008 | 1.871.059 | 1,48% | Aktien |
| Qube Research & Technologies Ltd | $2.028.866 | 1.779.707 | 1,41% | Aktien |
| CITADEL ADVISORS LLC | $1.958.131 | 1.717.659 | 1,36% | Aktien |
| UBS Group AG | $1.567.442 | 1.374.950 | 1,09% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.395.318 | 1.223.963 | 0,97% | Aktien |
| CITIGROUP INC | $1.282.010 | 1.124.570 | 0,89% | Aktien |
| MORGAN STANLEY | $799.756 | 701.540 | 0,55% | Aktien |
| Invesco Ltd. | $792.218 | 694.928 | 0,55% | Aktien |
| MANGROVE PARTNERS IM, LLC | $760.328 | 666.954 | 0,53% | Aktien |
| AMERIPRISE FINANCIAL INC | $713.823 | 626.160 | 0,49% | Aktien |
| Bank of New York Mellon Corp | $705.830 | 619.149 | 0,49% | Aktien |
| Nuveen, LLC | $680.123 | 596.599 | 0,47% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $672.396 | 589.821 | 0,47% | Aktien |
| TWO SIGMA ADVISERS, LP | $643.918 | 399.949 | 0,45% | Aktien |
| CHOREO, LLC | $641.162 | 562.423 | 0,44% | Aktien |
| Quantinno Capital Management LP | $640.820 | 562.123 | 0,44% | Aktien |
| Creative Planning | $622.144 | 545.740 | 0,43% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $606.265 | 531.813 | 0,42% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $531.832 | 466.519 | 0,37% | Aktien |
| BANK OF AMERICA CORP /DE/ | $522.976 | 458.750 | 0,36% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $493.325 | 354.910 | 0,34% | Aktien |
| Eversept Partners, LP | $486.888 | 427.095 | 0,34% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $408.376 | 358.627 | 0,28% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $368.904 | 323.600 | 0,26% | Aktien |
| VIRTUS ADVISERS, LLC | $359.940 | 315.737 | 0,25% | Aktien |
| RHUMBLINE ADVISERS | $350.544 | 307.503 | 0,24% | Aktien |
| Russell Investments Group, Ltd. | $342.416 | 300.367 | 0,24% | Aktien |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $336.186 | 294.900 | 0,23% | Aktien |
| ALPS ADVISORS INC | $310.379 | 272.262 | 0,21% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $304.722 | 267.300 | 0,21% | Verkaufsoption |
| JPMORGAN CHASE & CO | $298.634 | 269.040 | 0,21% | Aktien |
| DEUTSCHE BANK AG\ | $292.847 | 256.883 | 0,20% | Aktien |
| FRANKLIN RESOURCES INC | $286.156 | 251.014 | 0,20% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $279.072 | 244.800 | 0,19% | Kaufoption |
| WELLS FARGO & COMPANY/MN | $270.084 | 236.916 | 0,19% | Aktien |
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Muneer A. Satter (2) ×3 Einreichungen | 11. Januar 2019 | · | Erste Einreichung | M&A / Verkauf | SEC |
| Nantahala Capital Management, LLC, Wilmot B. Harkey, Daniel Mack ×2 Einreichungen | 21. Dezember 2018 | · | Erste Einreichung | Passive Anlage | SEC |
| Vifor (International) Ltd., Vifor Pharma Ltd. ×2 Einreichungen | 10. August 2017 | · | Erste Einreichung | · | SEC |
| Kearny Venture Partners, L.P. (“KVP”), Kearny Venture Partners Entrepreneurs’ Fund, L.P. (“KVPE”), Thomas Weisel Healthcare Venture Partners, L.P. (“TWHVP”), Kearny Venture Associates, L.L.C. (“KVA”), Caley Castelein (“Castelein”), Richard Spalding (“Spalding”), James Shapiro (“Shapiro”) ×2 Einreichungen | 20. Januar 2016 | · | Erste Einreichung | · | SEC |
| Novo A/S ×3 Einreichungen | 18. November 2015 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 38 Insider · 17 Führungskräfte · 20 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| John P. Butler | CEO and President | 6. August 2026 M | 3.718.564 | 1 | 4 | $-387.825 |
| Erik Ostrowski | SVP, CFO, CBO & Treasurer | 29. Juni 2026 S | 616.616 | 0 | 2 | $-110.763 |
| Ellen Snow | SVP, CFO and Treasurer | 31. Januar 2024 A | 519.300 | 0 | 0 | $0 |
| David A Spellman | SVP, CFO and Treasurer | 16. Mai 2023 S | 446.483 | 0 | 0 | $0 |
| Jason Amello | SVP, CFO & Treasurer | 28. Februar 2020 A | 144.642 | 0 | 0 | $0 |
| Michel Dahan | SVP, Chief Operating Officer | 13. Mai 2024 S | 672.092 | 0 | 0 | $0 |
| Carolyn M. Rucci | SVP, Chief Legal Officer | 2. Februar 2026 S | 588.378 | 0 | 3 | $-96.983 |
| Richard C Malabre | SVP, Chief Accounting Officer | 2. Februar 2026 S | 299.390 | 0 | 2 | $-68.838 |
| Nicholas Grund | Chief Commercial Officer | 2. Februar 2026 S | 561.750 | 0 | 2 | $-117.912 |
| Steven Keith Burke | SVP, Chief Medical Officer | 2. Februar 2026 S | 948.432 | 0 | 3 | $-94.044 |
| Nicole R. Hadas | SVP, Chief Legal Officer | 13. Mai 2024 S | 651.243 | 0 | 0 | $0 |
| Violetta Cotreau | SVP, Chief Accounting Officer | 12. Mai 2022 A | 219.954 | 0 | 0 | $0 |
| Dell Faulkingham | SVP, CCO | 28. Februar 2022 A | 173.841 | 0 | 0 | $0 |
| Karen L Tubridy | SVP, Chief Development Officer | 28. Februar 2020 A | 84.679 | 0 | 0 | $0 |
| Rita Jain | SVP, Chief Medical Officer | 11. April 2019 D | 96.332 | 0 | 0 | $0 |
| Bradley Maroni | SVP and Chief Medical Officer | 21. Februar 2017 A | 64.585 | 0 | 0 | $0 |
| Robert Shalwitz | Chief Medical Officer | 14. Mai 2014 A | 264.556 | 0 | 0 | $0 |
| Ron Frieson | Direktor | 17. Juni 2026 A | 165.200 | 0 | 0 | $0 |
| Myles Wolf | Direktor | 17. Juni 2026 A | 169.081 | 0 | 0 | $0 |
| Cynthia Smith | Direktor | 17. Juni 2026 A | 196.633 | 0 | 0 | $0 |
| Adrian Adams | Direktor | 17. Juni 2026 A | 236.200 | 0 | 0 | $0 |
| Michael W Rogers | Direktor | 17. Juni 2026 A | 197.429 | 0 | 0 | $0 |
| Leanne M Zumwalt | Direktor | 17. Juni 2026 A | 145.100 | 0 | 0 | $0 |
| Philip J. Vickers | Direktor | 1. April 2026 A | · | 0 | 0 | $0 |
| Steven C Gilman | Direktor | 10. Juni 2025 A | 152.830 | 0 | 0 | $0 |
| Michael Thomas Heffernan | Direktor | 2. Juni 2021 A | 48.586 | 0 | 0 | $0 |
| Mark J Enyedy | Direktor | 5. Juni 2020 A | 31.143 | 0 | 0 | $0 |
| Maxine Gowen | Direktor | 5. Juni 2020 A | 24.133 | 0 | 0 | $0 |
| Jodie Pope Morrison | Direktor | 6. Juni 2019 A | 58.619 | 0 | 0 | $0 |
| Scott A Canute | Direktor | 6. Juni 2019 A | 13.700 | 0 | 0 | $0 |
| Michael D. Clayman | Direktor | 14. Juni 2018 A | · | 0 | 0 | $0 |
| Duane Nash | Direktor | 14. Juni 2018 A | 21.499 | 0 | 0 | $0 |
| Ronald C Renaud JR | Direktor | 14. Juni 2018 A | 5.000 | 0 | 0 | $0 |
| Satter Muneer A | Direktor | 14. Juni 2018 A | 3.037.042 | 0 | 0 | $0 |
| Michael S Wyzga | Direktor | 14. Juni 2018 A | 1.500 | 0 | 0 | $0 |
| Anupam Dalal | Direktor | 16. Juni 2016 A | · | 0 | 0 | $0 |
| Novo Holdings A/S | · | 25. März 2014 C | 1.516.387 | 0 | 0 | $0 |
| Novartis Bioventures Ltd | · | 25. März 2014 C | 3.405.764 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 17 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,52% | 130.501 SH | 1. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,06% | 873.651 SH | 11. September 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,02% | 249.458 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 451.303 SH | 1. Oktober 2026 | Täglich |
| IWO · iShares Trust | 0,01% | 2.169.896 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 123.445 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 1.485.665 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 6.668.524 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 364.328 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 46.198 SH | 3. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 3.164.884 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 7.912.283 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 24.210 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 20.230 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,00% | 754.414 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 338.893 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 623.464 SH | 11. September 2026 | Täglich |
AKBA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 11 Analysten
KAUF
Median-Ziel
$4.00
+362,4%
4 36,4%
Starker Kauf
5 45,5%
Kauf
2 18,2%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
6 Analysten · 2026-10-03Mittelwert-Ziel $3.92 +352,8%
← Unter allen Zielen
Aktueller Preis $0.86
Tief$1.00
Mittelwert$3.92
Hoch$6.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | · |
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | · |
| QTTB | $43M | 1.4 | · | 55.5% | 200.3% | · |
| PALI | $375M | -7.8 | · | · | -25.4% | · |
| CAMP | $318M | -2.3 | 436.5% | -2298.5% | -183.4% | · |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | · |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | · |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 5, 2026